Taipei Exchange - Delayed Quote TWD

Aplus Biotechnology Corporation Limited (6918.TWO)

99.70
-0.30
(-0.30%)
At close: May 16 at 11:56:55 AM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
788,053
769,591
675,047
615,477
541,851
Cost of Revenue
237,947
234,813
214,373
243,943
195,464
Gross Profit
550,106
534,778
460,674
371,534
346,387
Operating Expense
355,926
352,497
292,968
304,930
300,242
Operating Income
194,180
182,281
167,706
66,604
46,145
Net Non Operating Interest Income Expense
155
75
-995
-1,822
-1,777
Pretax Income
196,906
187,556
3,038
68,112
46,058
Tax Provision
38,080
36,500
14,343
22,408
10,428
Net Income Common Stockholders
158,826
151,056
-11,305
45,704
32,941
Diluted NI Available to Com Stockholders
158,826
151,056
-11,305
45,704
32,941
Basic EPS
5.23
4.99
-0.37
1.50
1.15
Diluted EPS
5.21
4.97
-0.37
1.50
1.14
Basic Average Shares
30,375.19
30,281
30,254
30,471
28,649
Diluted Average Shares
30,460.19
30,366
30,254
30,548
28,711
Total Expenses
593,873
587,310
507,341
548,873
495,706
Net Income from Continuing & Discontinued Operation
158,826
151,056
-11,305
45,704
32,941
Normalized Income
158,682.42
150,912.64
-11,172.20
45,454.38
32,480.71
Interest Income
2,330
2,265
1,710
834
420
Interest Expense
2,175
2,190
2,705
2,656
2,197
Net Interest Income
155
75
-995
-1,822
-1,777
EBIT
199,081
189,746
5,743
70,768
48,255
EBITDA
225,953
216,443
32,123
95,631
69,684
Reconciled Cost of Revenue
237,947
234,813
214,373
243,943
195,464
Reconciled Depreciation
26,872
26,697
26,380
24,863
21,429
Net Income from Continuing Operation Net Minority Interest
158,826
151,056
-11,305
45,704
32,941
Total Unusual Items Excluding Goodwill
178
178
-166
372
595
Total Unusual Items
178
178
-166
372
595
Normalized EBITDA
225,775
216,265
32,289
95,259
69,089
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
34.42
34.64
-33.20
122.38
134.71
12/31/2021 - 1/6/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6815.TWO Diamond Biotechnology Co., Ltd
61.60
-1.44%
 
6934.TWO HCMED
62.10
+0.16%
 
6734.TWO iXensor Co., Ltd.
5.94
+12.08%
 
6572.TWO PlexBio Co., Ltd.
11.00
+4.76%
 
6797.TWO Taiwan Advanced Nanotech Inc.
16.20
+0.62%
 
7726.TWO CARILEX
36.85
-0.27%
 
6758.TWO A-SPINE Asia Co., Ltd.
32.00
0.00%
 
7555.TWO MEM Dental Technology Co., Ltd.
61.00
0.00%
 
4129.TWO United Orthopedic Corporation
101.50
+1.70%
 
6955.TW Bonraybio Co., Ltd.
164.00
0.00%